From screening to ongoing management, as well as surveillance during remission each cancer type will be addressed uniquely using the most current evidence. When new data with no historical academic documentation is discovered, the most knowledgeable experts on the topic will be engaged for determination of treatment course. Landmark studies have found that 19% of adult cancer patients having PET/MRI in addition to the standard of care PET/CT had a change in their disease management resulting from the additional findings by PET/MRI. In children with solid tumor cancers, closer to 50% had a change in disease management. This data can be found with PET/MRI alone, but was compared to PET/CT, which is the current Standard of Care.
Platinum care cancer screening clinics for Prostate, Breast, Pancreatic and other cancers will allow immediate visualization and plan for MRI guided biopsy when possible. Definitive diagnoses will be referred to local or national experts for further consultation on disease management. Q Institute will also engage consumers primary care physicians to educate them on current practices and provide access to Q’s expert network. For survivors of cancer requiring routine surveillance, the Q will provide a concierge membership setting so as to avoid the hospital or insurance based clinic setting and have immediate access to expertise for interpretation.
